1161 – Methodology Development Study in Stockholm

1161 – Methodology Development Study in Stockholm

Study 1161

We are looking for healthy individuals who would like to donate blood for a method development study.

The blood you donate will be used for research to develop new methods that could potentially be used in future treatments for cancer, autoimmune diseases, and other immunological conditions.

Target group: healthy individuals, ages 18–65  

Criteria for participation:

  • Be healthy
  • Not treated with anti-inflammatory or immunosuppressive medications
  • Not be pregnant, or intend to become pregnant, or be breastfeeding during the course of the study

The study consists of a telephone interview and a clinic visit. The clinic visit will take place at OptiCell Solutions in Huddinge and is expected to last about an hour. During the visit, you will be asked to provide up to 100 ml of blood from a vein in your arm.

Compensation:

300 SEK as compensation for your participation.

Available times:

Time for a clinic visit
March 30
April 13
April 20
April 27
May 4
May 11

More information and registration

Would you like to participate in the study? Submit an expression of interest using the form below.

Do you have questions or want to know more? Call 018-30 33 99 or email info@ctc-ab.se.

The study has been approved by the Ethical Review Authority. Your participation is voluntary, and you can withdraw at any time. The information you provide will be processed in accordance with the General Data Protection Regulation (GDPR).

Register your interest